Aiming at the molecular definition of the relationship(s) between prenatal infections and fetal microcephaly and using pentapeptides as minimal immune determinants, we analyzed the peptide matching between proteins from infectious agents involved in microcephalic syndromes (namely Zika virus, human Cytomegalovirus, and Toxoplasma gondii) and human proteins that, when altered, have been specifically associated with microcephaly. We report that an unexpected high number of epitopic pentapeptides (ie, 34) are common to the three fetopathogenic agents and repeatedly occur throughout an important number of microcephaly-related human proteins. The data introduce the issue of multiple cross-reactivity into the etiology on ZIKV-associated pathologies.
Minimal immune determinants connect Zika virus, human

| INTRODUCTION
Increasing evidence points to a direct causal link between prenatal Zika virus (ZIKV) infection and microcephaly and other brain anomalies in the fetus, [1] [2] [3] [4] but the pathogenic mechanism(s) of the Flavivirus Zika is unknown. Searching for molecular mechanisms that may help explain the relationship between ZIKV infection during pregnancy and the fetal pathologic sequela, we follow the hypothesis that anti-ZIKV immune responses induced by the viral infection might cross-react with human proteins involved in neurodevelopment, thus leading to brain malformations. Actually, we already showed that an impressing peptide sharing links ZIKV to human proteins that, when altered, are related to brain calcifications and microcephaly. 5 Here, we further explore the cross-reactivity hypothesis by comparatively analyzing the ZIKV polyprotein for phenetic relationships to other fetopathogens that can associate with the microcephalic syndrome. We reasoned that expanding peptide analyses to pathogens that have been invoked in brain anomalies might contribute to enlighten not only the ZIKV pathogenic mechanism but also the molecular link(s) between in utero infections and fetal brain malformations. 6 Indeed, fetal brain damages have been associated also with pathogens as diverse as a protozoan, ie, Toxoplasma gondii (T. gondii), and a herpesvirus, ie, human Cytomegalovirus (hCMV). 7, 8 On the other hand, other infectious agents belonging to the Flaviviridae family such as hepatitis C virus (HCV) or the closely ZIKV-related dengue virus (DENV) have not been reported to cause the same ZIKV brain damages. Therefore, searching for common molecular determinant(s) by which ZIKV and other fetopathogens may relate to the microcephalic syndrome, we focused on T. gondii and hCMV, which have been specifically associated with a high risk of microcephaly, [7] [8] [9] [10] [11] [12] [13] [14] [15] and used HCV and DENV as controls.
We attempted to answer two main questions: First, whether ZIKV, hCMV, and T. gondii are interconnected by common peptide sequences to human microcephaly-related proteins, and, second, whether the possible common sequences have an immunologic potential. We used pentapeptides as probes because a grouping of five amino acid (aa) residues can induce specific antibodies and specific antigen-antibody interactions [16] [17] [18] , and further references therein]. We found that many epitopic pentapeptides are shared by ZIKV, hCMV, and T. gondii, and recur throughout human microcephaly-associated proteins.
Findings are discussed in relationship to a potential role of multiple autoimmune reactions in the etiology of the fetopathogen-associated microcephalic syndrome.
| MATERIALS AND METHODS
Human microcephaly-related proteins were retrieved from UniProtKB Peptide matching was analyzed using PIR peptide match program (pir.georgetown.edu/pirwww/search/peptide.shtml).
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The immunological potential of the peptide sharing among infectious pathogens and human microcephaly-related proteins was investigated using the immune epitope database (IEDB; www.iedb.org) resource. 21 Only epitopes that had been experimentally validated as immunopositive in the human host were considered.
| RESULTS
| Quantitative description of the pentapeptide sharing between ZIKV polyprotein and human proteins related to microcephaly
We searched UniProtKB database 19 for human protein entries associated with the keyword "microcephaly." The keyword-guided search produced 208 protein entries that are described in Table S1 .
Then, using the pentapeptide as immune basic unit, [16] [17] [18] we con- (Table S1 and Fig. 1, Panel A) . The data exceed any theoretical expectations.
In fact, given the number N of all possible pentapeptides equal to On the whole, Figure 1 and Table 2 outline a viral vs human pentapeptide overlap of vast proportions and totally unexpected in light of the extremely low probability of one single pentapeptide occurring at random in two protein sequences.
| Qualitative description of the pentapeptide sharing between ZIKV polyprotein and human proteins related to microcephaly
| Pentapeptides shared between ZIKV and human microcephaly-related proteins: occurrences in hCMV and T. gondii
Each of the 384 ZIKV pentapeptides shared with the 156 microcephalyrelated proteins (see Table 1 ) was tested for occurrences in hCMV and
T. gondii proteomes and in the HCV and DENV proteome controls by using PIR peptide match program. That is, the pentapeptide platform common to ZIKV and microcephalic proteins (Table 1 ) was used to search for commonalities with the two fetopathogenic agents, hCMV and T. gondii. Results are reported in Table 2 and highlight the further unexpected datum that 41 pentapeptides are common to the three fetopathogens and repeatedly occur for a total of 58 occurrences throughout 41 human proteins related to microcephaly ( Table 2) . None of the 41 pentapeptides common to ZIKV, hCMV, and T. gondii was present in HCV; two were also shared with DENV (namely LSRKT and RGPSL). Solving the equation, one obtains E=7,041066614154769e-7.
That is, the probability of occurrence of the sharing of a pentapeptide among the three fetopathogens and the 41 human microcephaly-related proteins is practically null. In face of this,
F I G U R E 1 Actual and theoretical pentapeptide sharing between ZIKV polyprotein and 208 human proteins related to microcephaly. Proteins are indicated by UniProtKB entry names and are listed along the x-axis according to aa length (from MIRH1, 70 aa, to PCLO, 5065 aa). Proteins details in Table S1 . The arrows indicate pyrroline-5-carboxylate reductase 2 protein (P5CR2, 320 aa) and Rab3 GTPase-activating protein subunit (RBGPR, 1393 aa) as examples of peptide sharing independent from the protein length T A B L E 1 (continued) the pentapeptide commonality amounts to 41 pentapeptides for a total of 58 matches (including multiple occurrences). This contrast between expected vs found values clearly indicates a nonstochastic nature of the peptide overlapping among proteomes from the three infectious agents and the human host as already discussed elsewhere.
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In addition, Table 2 shows an uneven representation of the com- Further, although protein isoforms were not analyzed here because of space limitations, they nonetheless warrant some consideration. A representative example is given by the nine isoforms of transcription factor IIIB (TF3B) that, on the whole, host six of the 41 pentapeptides shared by ZIKV, hCMV, and T. gondii (Table 3) . The six T A B L E 2 (continued) (continues) pentapeptides are differentially displayed (from zero to four times) throughout the nine isoforms, so conferring a different (or no) crossreactivity potential to the various TF3B isoforms. Data from Table 3 suggest that analysis of isoform expression in fetuses might help evaluate different pathologic outcomes of ZIKV infection in pregnancies. Hereof, it is noteworthy to recall that studies on microcephaly at the genetic level have shown that microcephaly-associated mutations in TF3B gene 23 are pathogenic in an apparent isoformspecific context. 
| Immunological potential of the multiple sharing among fetopathogens and human proteins related to microcephaly
The immune epitope database (IEDB) was used to define the immunological potential of the peptide sharing illustrated in Table 2 .
Epitopes experimentally validated as immunopositive in humans were searched for instances of the pentapeptides listed in Table 2 .
It was found that, except 7 pentapeptides (namely DESGD Table 4 .
It appears that Table 4 substantiates cross-reactivity as a potential mechanistic link between prenatal infections, immune response of the host, and microcephalic syndrome in the fetus. As a matter of fact, the immunologic implications of the multiple peptide overlap described in text may be significant in regard to the link between ZIKV infection and fetal microcephalic syndrome. Indeed, principles of classical immunology 25 state that an organism subjected for the first time to an infection develops a weak response characterized by a low amount of low-avidity, low-affinity antibodies (mainly IgMs) that over time decline to the point to be practically undetectable. This is the so-called primary immune response. Then, a second encounter with the same or a related infectious pathogen results T A B L E 3 Distribution of pentapeptides shared by ZIKV, hCMV, and T. gondii throughout the nine isoforms of transcription factor IIIB 90 kD (TF3B)
into an accelerated production of high-avidity, high-affinity antibodies (mainly IgGs) that tend to persist in high concentrations for months/years. This is the so-called secondary immune response.
Translating all this into this study, the presence of minimal immune determinants common to hCMV and T. gondii may imply that ZIKVinfected pregnant women who had previously not been exposed to hCMV and/or T. gondii may develop a weak, transitory primary immune response of low/no pathologic impact. Vice versa, ZIKV infection in subjects previously exposed to hCMV and/or T. gondii has the potential to trigger high-avidity, high-affinity, abiding secondary immune response against minimal immune determinants already present in the immunological memory of the infected subject. Needless to say, the pathologic impact might be high. 
| CONCLUSION
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